Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neurodevelopmental Disabilities
How do you assess efficacy when trialing a patient with Rett syndrome on trofinetide (Daybue)?
Related Questions
How do you decide when to pursue genetic testing for cerebral palsy?
What behavioral interventions have you found most effective for managing self-injurious behavior in autism?
When and how do you perform genetic testing for congenital myasthenia gravis in seronegative cases?
When do you consider surgery for patients with Sturge Weber?
Do you use alcohol to trigger seizures in patients you suspect to have JME to confirm diagnosis?
How does choice of enzyme replacement therapy and monitoring parameters for late-onset Pompe disease differ from infantile onset disease?
How do you discontinue ketogenic diets previously used as a treatment for epilepsy?
How do you counsel on the risks of developing anti-drug antibodies when using intrathecal enzyme replacement therapy for lysosomal storage disorders?
How would you approach a toddler with alternating head tilt episodes lasting for weeks?
When do you consider cannabidiol for treatment of epilepsy?
